BEONE MEDICINES LTD. (ONC) Return on equity 2016–2025
BEONE MEDICINES LTD. (ONC) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
6.6%FY2025 · since FY2016: -33.8% → 6.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 6.6% | +25.9 pp |
| FY2024 | -19.4% | +5.6 pp |
| FY2023 | -24.9% | +20.8 pp |
| FY2022 | -45.7% | -21.9 pp |
| FY2021 | -23.8% | +18.2 pp |
| FY2020 | -42.0% | +56.6 pp |
| FY2019 | -98.6% | -59.8 pp |
| FY2018 | -38.7% | -24.8 pp |
| FY2017 | -13.9% | +19.9 pp |
| FY2016 | -33.8% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice